Methotrexate-associated lymphoproliferative disorder demonstrating composite lymphoma of EBV-negative diffuse large B-cell lymphoma and EBV-positive mucocutaneous ulcer
Open Access
- 1 January 2020
- journal article
- research article
- Published by Japanese Society for Lymphoreticular Tissue Research in Journal of Clinical and Experimental Hematopathology
- Vol. 60 (1) , 11-16
Abstract
Other iatrogenic immunodeficiency-associated lymphoproliferative disorders induced by immunosuppressive drugs, such as methotrexate (MTX-LPD), exhibit numerous pathological findings. We report the case of an 81-year-old Japanese woman diagnosed with MTX-LPD exhibiting two distinct pathological features from two different sites. Excisional biopsy of the left cervical lymph node revealed EBV-negative diffuse large B-cell lymphoma and biopsy of a pharyngeal ulcer revealed EBV-positive mucocutaneous ulcer. She was treated using an R-CHOP regimen and maintained complete remission for years. This case demonstrates the heterogeneous pathology of MTX-LPD and suggests the necessity of multiple biopsy.Keywords
This publication has 15 references indexed in Scilit:
- Clinical management for other iatrogenic immunodeficiency-associated lymphoproliferative disordersJournal of Clinical and Experimental Hematopathology, 2019
- A review of EBV-positive mucocutaneous ulcers focusing on clinical and pathological aspectsJournal of Clinical and Experimental Hematopathology, 2019
- Highlights: Focus on immunodeficiency-associated lymphoproliferative disordersJournal of Clinical and Experimental Hematopathology, 2019
- Restoration of Decreased T Helper 1 and CD8+ T Cell Subsets Is Associated With Regression of Lymphoproliferative Disorders Developed During Methotrexate TreatmentFrontiers in Immunology, 2018
- Clinicopathological analysis of methotrexate‐associated lymphoproliferative disorders: Comparison of diffuse large B‐cell lymphoma and classical Hodgkin lymphoma typesCancer Science, 2017
- Composite Cutaneous Lymphoma (Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorder) in a Patient with Rheumatoid Arthritis Treated with Methotrexate: Staging and Evaluation of Response to Therapy with 18F-FDG PET/CTNuclear Medicine and Molecular Imaging, 2016
- Methotrexate/iatrogenic lymphoproliferative disorders in rheumatoid arthritis: histology, Epstein–Barr virus, and clonality are important predictors of disease progression and regressionEuropean Journal of Haematology, 2013
- Composite Cutaneous Lymphoma in a Patient With Rheumatoid Arthritis Treated With MethotrexateThe American Journal of Dermatopathology, 2010
- Methotrexate-Associated Lymphoproliferative Disorder Mimicking Composite LymphomaInternational Journal of Hematology, 2006
- Survival and Clonal Expansion of Mutating “Forbidden” (Immunoglobulin Receptor–Deficient) Epstein-Barr Virus–Infected B Cells in Angioimmunoblastic T Cell LymphomaJournal of Experimental Medicine, 2001